All contents © Copyright 2014-2022 Neuro Leap Corp. All rights reserved.
Children love to play and learn like their friends; this is how they grow. Unfortunately many kids won’t have this opportunity, especially if they have special needs. These special children are misdiagnosed and under-treated 50% of the time (Guardian 2010). Not only does this cause a major impact on their well being and on our overall society.
The market for tools that aid in diagnosing people with special needs are at least $8 billion (marketsandmarkets.com).
Misdiagnosis and failed treatment happens every day, especially in the mental health field. Brain plasticity in children is one of the contributing factors. One-third of children with some form of
learning disability remain undiagnosed (Shaywitz, 2003). Our complex brain development makes it challenging to figure out the root cause of the disability.
We are collaborating with major research hospitals, as in US, there is a huge untapped market of 34 million children that are diagnosed with neuropsychological or neurodevelopmental conditions, such as Autism, ADHD, Cerebral Palsy, Down Syndrome, Language Disorders or Dyslexia. In addition, 5.8 million people suffer from stroke each year. Our medical device works with all of these conditions, and enables the earliest assessment and intervention possible.